Preview

Issues of Clinical Trials in India by Vallinadh Karamcheti

Powerful Essays
Open Document
Open Document
2567 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Issues of Clinical Trials in India by Vallinadh Karamcheti
Clinical trials in INDIA- Legal issues
By: Vallinadh Karamcheti
Abstract: Clinical trials are conducted to ensure the safety and efficacy of the drug. They are conducted on the human subjects. Hence the clinical trials are liable to many legal aspects. Clinical trials are conducted in four phases. (Phase I, Phase II, Phase III, & Phase IV). All the phases of the clinical trials should comply with several legal aspects, as life of a person may be at risk if anything goes wrong with the clinical trials. They should comply with the Schedule Y of Drugs and Cosmetics Act, 1940, Drugs and Cosmetics (II Amendment Rules) Rules 2005, Good Clinical Practices guidelines, 2001 etc.
What are clinical trials?
Clinical trials are the tests conducted on human subjects to test the safety, efficacy, tolerability, and phamaco-kinetic properties of the drug.
Why and how are they conducted?
Clinical trials are conducted in four phases
• Phase I trials are performed on a small group (normally 20-80) of normal healthy volunteers, and their aim is to check for safety (does the drug produce any potentially dangerous effects, for example on cardiovascular, respiratory, hepatic or renal function?), tolerability (does the drug produce any unpleasant symptoms, for example headache, nausea, drowsiness?) and pharmacokinetic properties (is the drug well absorbed? What is the time course of the plasma concentration? Is there evidence of cumulation or non-linear kinetics?). Phase I studies may also test for pharmacodynamic effects in volunteers (e.g. does a novel analgesic compound block experimentally induced pain in humans? How does the effect vary with dose?).

• Phase II studies are performed on groups of patients (normally 100-300) and are designed to test for efficacy in the clinical situation, and if this is confirmed, to establish the dose to be used in the definitive phase III study. Often, such studies will cover several distinct clinical disorders (e.g. depression, anxiety



References: http://cdsco.nic.in/html/copy%20of%201.%20d&cact121.pdf http://cdsco.nic.in/html/GCP.htm http://dbtbiosafety.nic.in/act/Schedule_Y.pdf http://www.thehindu.com/todays-paper/tp-national/tp-andhrapradesh/article2133307.ece?css=print http://www.halsburys.in/regulation-of-clinical-trials.html http://clinicaltrials.gov/ct2/info/understand Text book: RANG and DALE’S Pharmacology referred for Drug discovery and development

You May Also Find These Documents Helpful

  • Good Essays

    Bill 481: A Case Study

    • 1150 Words
    • 5 Pages

    Dr. James Quinn has been involved with clinical research in Idaho and Salt Lake City, Utah for the majority of his life. Although, Dr. Quinn has recently retired from clinical work he still keeps up with material that pertains to clinical research and is extremely passionate when it comes to House bill 481. Dr. Quinn expressed his passion as he talked about the importance of getting House bill 481 passed. Dr. Quinn described the three phases of the FDA in great detail. Phase 1 is the testing phase of the drug. During this phase test subjects take the drug,…

    • 1150 Words
    • 5 Pages
    Good Essays
  • Satisfactory Essays

    BUS 311 Week 5 Quiz

    • 401 Words
    • 2 Pages

    11. The phase of drug testing that the safety and effectiveness of the drug is evaluated in trials involving a great number of people is…

    • 401 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    BIO 275 AP 1

    • 707 Words
    • 2 Pages

    Phase I usually lasts 1 ½ years. Drug Company or sponsor conduct the study on 10 to 100 volunteers who don’t have any medical conditions. Company must to provide the inform consent where has to be included all possible risks and known effects of the new drug. During phase I is studied the correct dose, side effects and the possible toxicity. During the test volunteers are provided with medical examinations. Also this part of the testing a pharmacokinetics are studied as well.…

    • 707 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    TCO 2 deals with new experimental drugs and the steps required to bring new drugs to market. The first application paper deals with this as well. Describe the steps that are required to bring a new pharmaceutical to market. Address topics like human testing, the role of the FDA in approving new drugs, and the cost incurred by drug companies when developing new drugs.…

    • 660 Words
    • 3 Pages
    Satisfactory Essays
  • Satisfactory Essays

    Owl Pellet Dissection

    • 324 Words
    • 1 Page

    determines if the product will be tested on humans and if the product works in the way it should…

    • 324 Words
    • 1 Page
    Satisfactory Essays
  • Satisfactory Essays

    PSY 326 Research Methods

    • 2132 Words
    • 9 Pages

    You have been approached by a pharmaceutical company that has developed a new drug that is supposed to be effective in the treatment of schizophrenia. Before mass producing the drug they want to be sure that it is more effective than the drug they are currently producing. They have hired you to design a research study to determine the effectiveness of the new drug compared with the old one.…

    • 2132 Words
    • 9 Pages
    Satisfactory Essays
  • Powerful Essays

    Pharmacology Review Sheet

    • 11954 Words
    • 48 Pages

    This term refers to how much of a drug must be given to see a desired response…

    • 11954 Words
    • 48 Pages
    Powerful Essays
  • Powerful Essays

    Clinical Trials: Journal of the Society for Clinical Trials is an international peer reviewed scholarly. The primary aim is the “dissemination and development of knowledge about the design, conduct, analysis, synthesis, history, ethics, regulation and clinical or policy impact of all types of clinical trials and related medical research methodologies.” (Sage Journals, 2013).…

    • 866 Words
    • 4 Pages
    Powerful Essays
  • Satisfactory Essays

    Phase I Trail

    • 343 Words
    • 1 Page

    In order for investigators to gain legitimate consent to Phase I trial, they should first of all make sure they find healthy participants who are fit for the experiment. The investigators should be able and make sure that they explain the aim of the clinical trial to the participants, making sure that the subject has enough time to consider all options, answer all participant questions with honesty and truthfulness before any decision is made. The investigators should also make sure all information is well understood, the benefits and risk involved during this experiment. They should also make sure that everyone that accept to participate, should not be doing it for their own self-interest.…

    • 343 Words
    • 1 Page
    Satisfactory Essays
  • Good Essays

    This will be less stressful to figure out. Another suggestion would be more rigorous laws should be developed so the citizens of the country participating in the trials are not being injured. If possible, the individuals who are being exposed in the trials should have some kind of benefit besides the medical benefit for participating in the trial. With some changes, it would not only benefit the pharmaceutical company, but it would benefit the participating patient as…

    • 459 Words
    • 2 Pages
    Good Essays
  • Better Essays

    Fda Research Paper

    • 2368 Words
    • 10 Pages

    Americans must wait up to 19 years after a discovered treatment before they can participate in benefits of a new medication (Philipson & Sun, 2008). The regulatory process drug manufacturers need to endure before releasing potentially life-saving medication is an extremely expensive, time-consuming process. The Center for Drug Evaluation and Research (CDER) is the main department of the Food and Drug Administration (FDA) responsible for the safety of drugs (both prescription and over-the-counter) sold in the United States (Food and Drug Administration, 2011). This department scrutinizes the testing of new drugs and determines if they are safe and effective before distribution. They do not perform in-house testing themselves; they only evaluate the testing done by the manufacturer to make sure the drug claim is accurate and that the benefits of the medication out way the side-effects (Food and Drug Administration, 2011). Whereas the FDA’s regulation and oversight protects dangerous products from circulation, the approval process hinders manufacturers’ ability to release drugs in a timely manner because of the legal and cost liability, thus preventing the availability of treatment to Americans.…

    • 2368 Words
    • 10 Pages
    Better Essays
  • Best Essays

    Due to the complexities of clinical decision making that a physical therapist has to face everyday, the need to develop good clinical reasoning skill is essential. Although clinical reasoning can be developed through experience, confiding entirely on this, can result in faulty decisions as it can be influenced by biases and heuristics (Crist, McVay & Marocco, 2015). Employing the best, current evidence available to compliment our clinical skills and patient values can promote good patient outcome.…

    • 1564 Words
    • 7 Pages
    Best Essays
  • Good Essays

    Animal testing is rarely successful since animals have different physiologies than humans. There has been many studies that have shown inaccuracy and unsuccess in animal testing. Studies show, “90 percent of medications approved for human use after animal testing later proved ineffective or harmful to humans in clinical trials” (Stop Animal Testing) and also, “Animal-tested drugs have killed, disabled or harmed millions of people and lead to costly delays as well” (Stop Animal Testing). It is evident that animal testing lacks accuracy and has dangerous consequences, therefore it should no longer be…

    • 620 Words
    • 3 Pages
    Good Essays
  • Better Essays

    trials of investigation medical products. The FDA also has to review and approve in a…

    • 1228 Words
    • 5 Pages
    Better Essays
  • Better Essays

    If you were laying on your deathbed and there happened to be a cure for your disease, wouldn’t you want to have access to it? Even if the experimental drug was not 100 percent guaranteed to benefit you, at least you are giving yourself a chance to survive. On the other hand, it can be extremely difficult for clinical trial director’s to get the data that they need, without it being rather skewed. Generally, a clinical trial would not want to accept a patient who is terminally ill for the fact that it might be too late for any new drug to help them survive. Based on that transpiring multiple times throughout a clinical trial, then the data for that drug is going to be atrocious. A possible life-saving drug is going to be simply thrown out the…

    • 2463 Words
    • 10 Pages
    Better Essays